Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines Atlanticus Holdings ATLCP Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat Stock Rises Soligenix SNGX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Slips ORLY Q1 2026 Earnings EPS Surpasses Estimates Shares Slip Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses FDMT Q1 2026 Earnings NarrowerThanExpected Loss Highlights Clinical Progress